Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: EXPANDED DISABILITY STATUS SCALE, . Treffer: 23

2018

Eshaghi, A; Marinescu, RV; Young, AL; Firth, NC; Prados, F; Jorge Cardoso, M; Tur, C; De Angelis, F; Cawley, N; Brownlee, WJ; De Stefano, N; Laura Stromillo, M; Battaglini, M; Ruggieri, S; Gasperini, C; Filippi, M; Rocca, MA; Rovira, A; Sastre-Garriga, J; Geurts, JJG; Vrenken, H; Wottschel, V; Leurs, CE; Uitdehaag, B; Pirpamer, L; Enzinger, C; Ourselin, S; Gandini Wheeler-Kingshott, CA; Chard, D; Thompson, AJ; Barkhof, F; Alexander, DC; Ciccarelli, O Progression of regional grey matter atrophy in multiple sclerosis.
Brain. 2018; 141(6):1665-1677 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Eshaghi, A; Prados, F; Brownlee, WJ; Altmann, DR; Tur, C; Cardoso, MJ; De Angelis, F; van de Pavert, SH; Cawley, N; De Stefano, N; Stromillo, ML; Battaglini, M; Ruggieri, S; Gasperini, C; Filippi, M; Rocca, MA; Rovira, A; Sastre-Garriga, J; Vrenken, H; Leurs, CE; Killestein, J; Pirpamer, L; Enzinger, C; Ourselin, S; Wheeler-Kingshott, CAMG; Chard, D; Thompson, AJ; Alexander, DC; Barkhof, F; Ciccarelli, O; MAGNIMS study group Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Ann Neurol. 2018; 83(2):210-222 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Burgetova, A; Dusek, P; Vaneckova, M; Horakova, D; Langkammer, C; Krasensky, J; Sobisek, L; Matras, P; Masek, M; Seidl, Z Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.
AJNR Am J Neuroradiol. 2017; 38(6):1079-1086 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Sormani, MP; Gasperini, C; Romeo, M; Rio, J; Calabrese, M; Cocco, E; Enzingher, C; Fazekas, F; Filippi, M; Gallo, A; Kappos, L; Marrosu, MG; Martinelli, V; Prosperini, L; Rocca, MA; Rovira, A; Sprenger, T; Stromillo, ML; Tedeschi, G; Tintorè, M; Tortorella, C; Trojano, M; Montalban, X; Pozzilli, C; Comi, G; De Stefano, N; MAGNIMS study group Assessing response to interferon-β in a multicenter dataset of patients with MS.
Neurology. 2016; 87(2):134-140
Web of Science PubMed FullText FullText_MUG

 

2015

Cantó, E; Tintoré, M; Villar, LM; Costa, C; Nurtdinov, R; Álvarez-Cermeño, JC; Arrambide, G; Reverter, F; Deisenhammer, F; Hegen, H; Khademi, M; Olsson, T; Tumani, H; Rodríguez-Martín, E; Piehl, F; Bartos, A; Zimova, D; Kotoucova, J; Kuhle, J; Kappos, L; García-Merino, JA; Sánchez, AJ; Saiz, A; Blanco, Y; Hintzen, R; Jafari, N; Brassat, D; Lauda, F; Roesler, R; Rejdak, K; Papuc, E; de Andrés, C; Rauch, S; Khalil, M; Enzinger, C; Galimberti, D; Scarpini, E; Teunissen, C; Sánchez, A; Rovira, A; Montalban, X; Comabella, M Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Brain. 2015; 138(Pt 4):918-931 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jehna, M; Pirpamer, L; Khalil, M; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Deutschmann, H; Fazekas, F; Enzinger, C Periventricular lesions correlate with cortical thinning in multiple sclerosis.
Ann Neurol. 2015; 78(4): 530-539.
Web of Science PubMed FullText FullText_MUG

 

Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
Neurology. 2015; 84(24): 2396-2402.
Web of Science PubMed FullText FullText_MUG

 

2014

Ropele, S; Kilsdonk, ID; Wattjes, MP; Langkammer, C; de Graaf, WL; Frederiksen, JL; Larsson, HB; Yiannakas, M; Wheeler-Kingshott, CA; Enzinger, C; Khalil, M; Rocca, MA; Sprenger, T; Amann, M; Kappos, L; Filippi, M; Rovira, A; Ciccarelli, O; Barkhof, F; Fazekas, F Determinants of iron accumulation in deep grey matter of multiple sclerosis patients.
Mult Scler. 2014; 20(13):1692-1698
Web of Science PubMed FullText FullText_MUG

 

2013

Pichler, A; Enzinger, C; Fuchs, S; Plecko-Startinig, B; Gruber-Sedlmayr, U; Linortner, P; Langkammer, C; Khalil, M; Ebner, F; Ropele, S; Fazekas, F Differences and similarities in the evolution of morphologic brain abnormalities between paediatric and adult-onset multiple sclerosis.
Mult Scler. 2013; 19(2):167-172
Web of Science PubMed FullText FullText_MUG

 

2011

Enzinger, C; Fuchs, S; Pichler, A; Wallner-Blazek, M; Khalil, M; Langkammer, C; Ropele, S; Fazekas, F Predicting the severity of relapsing-remitting MS: The contribution of cross-sectional and short-term follow-up MRI data.
Mult Scler. 2011; 17(6): 695-701.
Web of Science PubMed FullText FullText_MUG

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Ropele, S; Fuchs, S; Khalil, M; Pluta-Fuerst, A; Fazekas, F; Enzinger, C Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces.
Brain Imaging Behav. 2011; 5(4): 241-251.
Web of Science PubMed FullText FullText_MUG

 

2006

Burwick, RM; Ramsay, PP; Haines, JL; Hauser, SL; Oksenberg, JR; Pericak-Vance, MA; Schmidt, S; Compston, A; Sawcer, S; Cittadella, R; Savettieri, G; Quattrone, A; Polman, CH; Uitdehaag, BM; Zwemmer, JN; Hawkins, CP; Ollier, WE; Weatherby, S; Enzinger, C; Fazekas, F; Schmidt, H; Schmidt, R; Hillert, J; Masterman, T; Hogh, P; Niino, M; Kikuchi, S; Maciel, P; Santos, M; Rio, ME; Kwiecinski, H; Zakrzewska-Pniewska, B; Evangelou, N; Palace, J; Barcellos, LF APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
NEUROLOGY. 2006; 66(9): 1373-1383.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Li, DK; Held, U; Petkau, J; Daumer, M; Barkhof, F; Fazekas, F; Frank, JA; Kappos, L; Miller, DH; Simon, JH; Wolinsky, JS; Filippi, M; Sylvia Lawry Centre for MS Research MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.
NEUROLOGY. 2006; 66: 1384-1389.
Web of Science PubMed FullText FullText_MUG

 

2004

Hommes, OR; Sørensen, PS; Fazekas, F; Enriquez, MM; Koelmel, HW; Fernandez, O; Pozzilli, C; O'Connor, P Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial.
Lancet. 2004; 364(9440):1149-1156
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Enzinger, C; Ropele, S; Strasser-Fuchs, S; Kapeller, P; Schmidt, H; Poltrum, B; Schmidt, R; Hartung, HP; Fazekas, F Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.
Arch Neurol. 2003; 60(1):65-70 [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

Niederwieser, G; Buchinger, W; Bonelli, RM; Berghold, A; Reisecker, F; Költringer, P; Archelos, JJ Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis.
J Neurol. 2003; 250(6):672-675
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Kapeller, P; Brex, PA; Chard, D; Dalton, C; Griffin, CM; McLean, MA; Parker, GJ; Thompson, AJ; Miller, DH Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis.
Mult Scler. 2002; 8(3):207-210
Web of Science PubMed FullText FullText_MUG

 

Sorensen, PS; Fazekas, F; Lee, M Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis.
Eur J Neurol. 2002; 9(6):557-563
Web of Science PubMed FullText FullText_MUG

 

2001

Balássy, C; Bernert, G; Wöber-Bingöl, C; Csapó, B; Kornek, B; Széles, J; Fleischmann, D; Prayer, D Long-term MRI observations of childhood-onset relapsing-remitting multiple sclerosis.
Neuropediatrics. 2001; 32(1):28-37
Web of Science PubMed

 

1999

Zimmermann, C; Walther, EU; Goebels, N; Lienert, C; Kappos, L; Hartung, HP; Hohlfeld, R Interferon beta-1b for treatment of secondary chronic progressive multiple sclerosis
Nervenarzt. 1999; 70(8):759-763
Web of Science PubMed FullText

 

1998

Ebers, GC; Rice, G; Lesaux, J; Paty, D; Oger, J; Li DKB, Beall S, Devonshire V, Hashimoto S, Hooge J, Kastrukoff L, Krieger C, Mezei M, Seland P, Vorobeychi G, Morrison W, Nelson J, Freedman MS, Chrisie S, Nelson R, Rabinovitch H, Freedman C, Hartung HP, Rieckmann P, Archelos J, Jung S, Weilbach F, Flachenecke P, Sauer J, Hommes O, Jongen P, Brouwer S, McLeod J, Pollard J, Ng R, Sandberg-Wollheim M, Kallen K, Nilsson P, Ekberg R, Lundgren A, Jadback G, Wikstrom J, Multanen J, Valjakka M, Carton H, Lissoir F, Declerq I, Vieren M, Peeters E, Dubois B, Dekeersmaeker E, Van Herle A, Hughes RAC, Sharrack B, Soudain S, Panelius M, Eralinna J, Soilu-Hanninen M, Murto S, Medaer R, Broeckx J, Vanroose E, Bogaers A, Blumhardt LD, Edwards S, Liu C, Orpe V, Barnes D, Schwartz M, Stoy N, Harraghy C, Bertelsmann F, Uitdehaag B, Nasseri K, Chofflon M, Roth S, Kappos L, Huber S, Bellaiche Y, Senn C, King J, Jubert J, Whitten S, Newsom-Davis JM, Palace J, Lee M, Evangelou N, Pinto A, Cavey A, Sindic CJM, Monteyne P, Verougstraete D, Van Doorn PA, Moll W, Visser L, Willems M, Martina I, Buljevac D, Loman L, Bates D, Pandit D, Irving J, Rhodes B, Riddehough A, Zhao GJ, Wang X, Cheng Y, Ammoury N, Dupont F, Galazka A, Hyde R, Olson M, Pernin MO, Abdul-Ahad AK, Hommes O, Noseworthy J, Borden E, O'Brien P, Wolinsky J Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
LANCET. 1998; 352(9139): 1498-1504.
Web of Science PubMed

 

Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Dahlke, F; Knight R, Hern J, Coleman R, Gerrie L, Cooper G, Moore J, Boringa J, van Oosten B, Ronner H, Schrijver H, Truyen L, Montalban J, Rio J, Tintore M, Jacas C, Marzo E, Lechner-Scott J, Huber S, Lienert C, Brunnschweiler H, Hawkins S, Droogan A, McDonnell G, Duddy M, McKinstry S, Altenkirch H, Baum K, Einhaupl K, Marx P, Poewe W, Walter G, Akman H, Brockmeier B, Scherer P, Zschenderlein R, Schmierer K, Gelderblom H, Hartmann A, Stapf C, Luschow A, Mackert B, Schumacher H, Masuhr F, Hempel T, Zimmermann R, Munch M, Francis D, Heafield M, Al-Memar A, Winer J, Chong M, Brochet B, Gayou A, Auriacombe S, Dousset V, Wiles C, Thomas F, Pickersgill T, Hinds N, Dawson K, Hughes T, Hutchinson M, Murphy R, Redmond J, Webb S, Stoll G, Jander S, Hagemann G, Koller H, Hanemann C, Kolmel H, Reichel D, Petereit K, Thieme A, Khatami A, Neumann M, Amaducci L, Massacesi L, Siracusa G, Amato M, Bartolozzi L, Repice A, Minderhoud J, De Keyser J, Zorgdrager A, Zwanikken C, Poser S, Polak T, Gunther A, Bitsch A, Borner T, Weber F, Wikstrom J, Farkkila M, Majuri H, Sumelahti M, Telakivi T, Fredrikson S, Martin C, Miller D, O'Riordan J, Brex P, Kapoor R, Werring D, Confavreux C, Brunet P, Hannoun D, Brudon F, Moreau T, Blanc S, D'Hooghe M, Jacobs K, Lissoir F, Demonty L, Comi G, Colombo B, Rossi P, Rodegher M, Santuccio G, Martinelli F, Hohlfeld R, Walther E, Goebels N, Dang T, Lindert R, Voltz R, Cartlidge N, Bates D, Moran G, Pandit L, Westwood M, Haller P, Sommer J, Bitter J, Suss F, Mellies J, Mucha P, Lyon-Caen O, Degos JD, Roullet E, Lubetzki C, Creange A, Tourbah A, Pez D, Lecanuet P, Nicolt P, Edan G, Belliard S, De Marco O, Cahagne V, De Burghgraeve V, Brunet I, Fieschi C, Millefiorini E, Gasperini C, Buttinelli C, Frontini M, Howell S, Hadjivassiliou M, Gibson A, Graham A, Harkness K, Lawden M, Clanet M, Wauban E, Azais-Vuillemin C, Lau GKK, Louis C, Panelius M, Ruutiainen J, Eralinna J, Soilu-Hanninen M, Gold R, Hartung HP, Jung S, Bayas A, Flachenecker P, Weilbach F, Archelos J, Kollegger H, Vass K, Asenbaum S, Chatsakos T, Beckmann K, Ghazi M, Wagner K, Miltenburger C, McFarland H, Petkau J, Sabouraud O, Toyka K Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
LANCET. 1998; 352(9139): 1491-1497.
Web of Science PubMed

 

1997

Fazekas, F; Deisenhammer, F; Strasser-Fuchs, S; Nahler, G; Mamoli, B Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group.
Lancet. 1997; 349(9052):589-593
Web of Science PubMed FullText Google Scholar

 

© Meduni Graz Impressum